Cabotegravir (sodium), CAS [[1051375-13-3]]

Catalog Number: MCE-HY-15592A
Article Name: Cabotegravir (sodium), CAS [[1051375-13-3]]
Biozol Catalog Number: MCE-HY-15592A
Supplier Catalog Number: HY-15592A
Alternative Catalog Number: MCE-HY-15592A-100MG,MCE-HY-15592A-50MG,MCE-HY-15592A-25MG,MCE-HY-15592A-10MMX1ML,MCE-HY-15592A-5MG,MCE-HY-15592A-10MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: GSK-1265744 (sodium), S/GSK1265744 (sodium)
Cabotegravir (GSK-1265744) sodium is a orally active and long-acting HIV integrase strand transfer inhibitor and organic anion transporter 1/3 (OAT1/OAT3) inhibitor with IC50 values of 2.5 nM, 0.41 µM and 0.81 µM for HIVADA, OAT3 and OAT1, respectively. Cabotegravir sodium is primarily metabolized by uridine diphosphate glucuronosyltransferase (UGT) 1A1, with low potential to interact with other antiretroviral agents (ARVs). Cabotegravir sodium can be used to research AIDS[1][2].
Molecular Weight: 427.33
Purity: 99.87
CAS Number: [1051375-13-3]
Formula: C19H16F2N3NaO5
Target: HIV,HIV Integrase,OAT
Application Notes: MCE Product type: Reference compound